Breaking Down Sichuan Hexie Shuangma Co., Ltd. Financial Health: Key Insights for Investors

Dive into a data-driven look at Sichuan Hexie Shuangma Co., Ltd. where 2024 revenue fell to ¥1.07 billion (down 11.87% year-over-year) even as the company projects a dramatic rebound with a Q1 2025 net profit guidance of ¥100-140 million (up 1,047%-1,506%); meanwhile profitability shows contrasts - net income dropped to ¥309.38 million in 2024 (a decline of 68.61%) despite a reported ROE of 4.6% and net margins of 28.7%, and balance-sheet indicators reveal conservative leverage with a debt-to-equity of 0.08, short-term debt of ¥158.7 million, an interest coverage ratio of 28.71 and liquidity metrics like a current ratio of 1.83 and quick ratio of 1.43; valuation multiples such as a trailing P/E of 35.28 and P/S of 12.85 contrast with heavy R&D investment (¥150 million in 2022, ~4.7% of revenue) and growth initiatives-set against an ESG risk score of 37.8, a market cap of ¥15.25 billion (EV ¥15.63 billion) and regional market share of 30% in southwestern China-read on to unpack what these figures mean for investors weighing risk, valuation and upside.

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Revenue Analysis

2024 revenue: 1.07 billion yuan, down 11.87% from 2023's 1.22 billion yuan. The company's revenue has been declining at an average annual rate of 4.1% versus the Basic Materials industry's 17.0% average annual decline. Management cites softer construction materials demand and intensified competition as primary drivers.

• 2024 revenue: 1.07 billion yuan (-11.87% YoY)
• 3-year average revenue decline: -4.1% CAGR
• Industry (Basic Materials) average decline: -17.0% annually
• Regional market share (Southwestern China, 2022): 30%
• R&D spend (2022): 150 million yuan (~4.7% of revenue)

Profit outlook and quarterly context:

• Drivers of the Q1 2025 swing: potential one-off items, operating leverage on reduced cost base, or recovery in select end-markets.
• Risks: sustained weakness in construction materials demand and margin pressure from competition.

For background on corporate strategy, ownership and how the company generates revenue, see: Sichuan Hexie Shuangma Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Profitability Metrics

• 2024 net income: 309.38 million yuan (-68.61% vs. 2023: 981.99 million yuan)
• Current ROE: 4.6%; historical ROE: 3.16% (2016) → 14.10% (2023)
• Net margin: 28.7%
• Operating margin: consistent improvement over the past three years (reflects cost management and production efficiency)
• Long-term net profit growth: from 0.85 billion yuan (2016) to 9.85 billion yuan (2023)
• Alternate reported series: net profit rose from 3.61 billion yuan (2018) to 8.52 billion yuan (2023), representing 86% of net profit in that period
• Primary near-term drivers of the 2024 net income decline: higher operating costs and lower revenue

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Debt vs. Equity Structure

• Debt-to-equity ratio: 0.08 - indicates minimal leverage relative to shareholders' equity.
• Short-term debt (as of 2025-03-31): ¥158.7 million - liquidity timing to watch for near-term obligations.
• Interest coverage ratio: 28.71 - ample earnings cushion to meet interest expenses.
• Enterprise value: ¥15.63 billion vs. market capitalization: ¥15.25 billion - EV slightly above market cap, reflecting modest net debt.
• Controlling shareholder pledge: Beijing Harmony Hengyuan Technology has pledged 16,666,667 shares (4.12% of its holdings; 2.18% of total share capital) as collateral for debt repayment.
• Total liabilities: increasing trend - potential pressure on financial stability if the rise continues without earnings growth or deleveraging.

• Implications for investors: low leverage reduces default risk and increases flexibility for capital allocation, but rising total liabilities could signal emerging funding needs.
• Monitoring points: short-term debt maturity profile, trajectory of total liabilities, and any further share pledges by major shareholders.

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Liquidity and Solvency

• Current ratio: 1.83 - sufficient current assets to cover short-term liabilities.
• Quick ratio: 1.43 - adequate immediate liquidity excluding inventories.
• Debt-to-EBITDA: 1.60 - moderate leverage, implying roughly 1.6 years of EBITDA to cover outstanding debt.
• Debt-to-free cash flow: 1.64 - manageable debt relative to cash generation after capital expenditures.
• Interest coverage ratio: 28.71 - strong capacity to meet interest expenses (EBIT / interest expense).
• Solvency trend: ratios have remained stable period-over-period, reflecting consistent financial health.

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Valuation Analysis

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) displays premium market valuation across multiple commonly used multiples, signaling strong investor appetite relative to fundamentals.

• Trailing P/E: 35.28 - notably above typical industry averages, implying investors price in above‑average earnings growth or lower perceived risk.
• P/B: 1.99 - near book value, indicating the market values the company close to its net asset base.
• P/S: 12.85 - high relative to sales, suggesting revenue is being valued at a significant premium.
• P/FCF: 39.31 - elevated, showing the market pays a substantial premium for each unit of free cash flow.
• P/OCF: 33.97 - also high, reflecting premium valuation versus operating cash generation.
• Valuation momentum: the company's multiples have been increasing, consistent with rising investor confidence and demand for the stock.

Key investor considerations:

• Premium P/E and elevated cash‑flow multiples imply the market expects continued earnings/cash‑flow expansion or assigns a scarcity/growth premium.
• P/B near 2.0 suggests limited latent downside from book-value reversion but less margin of safety than low P/B names.
• High P/S highlights reliance on future margin expansion to justify current price.
• Rising valuation metrics increase sensitivity to any earnings or cash‑flow disappointments; monitoring quarterly results and guidance is important.

For further context on shareholder composition and recent investor activity, see: Exploring Sichuan Hexie Shuangma Co., Ltd. Investor Profile: Who's Buying and Why?

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Risk Factors

• ESG risk rating: 37.8 - categorized as high ESG risk, exposing the company to environmental, social, and governance-related operational and reputational challenges.
• Controlling shareholder pledge: the controlling shareholder has pledged a significant portion of shares, increasing the risk of forced sales and dilution of minority shareholder value if margin calls or creditor actions occur.
• Revenue trend: reported declining revenue in recent periods, which pressures margins and cash generation capacity.
• Debt trajectory: total debt levels have been increasing, raising leverage and interest burden risks, and reducing financial flexibility.
• Market competition: held ~30% market share in southwestern China in 2022, indicating meaningful exposure to regional competitive dynamics and potential share erosion.
• Profitability shock: net profit declined by 68.61% in 2024, a sharp drop that can materially affect investor confidence and valuation multiples.

• Liquidity risk: declining revenue plus rising debt elevates short-term liquidity and covenant breach risk; monitor cash flow from operations and available credit facilities.
• Shareholder concentration risk: heavy pledge by controlling shareholder can translate into sudden market supply if deleveraging is required.
• Operational risk: high ESG score signals potential environmental/regulatory exposures that could lead to fines, remediation costs, or operational interruptions.
• Market risk: 30% regional share in 2022 shows susceptibility to competitive price pressure and regional economic cycles.
• Investor sentiment risk: a 68.61% net profit decline in 2024 can prompt rating downgrades, higher borrowing costs, and compressed equity valuations.

Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) - Growth Opportunities

• R&D commitment: R&D expenses reached ¥150 million in 2022, about 4.7% of 2022 revenue (implied 2022 revenue ≈ ¥3.191 billion), underpinning innovation-led product and service expansion.
• Strategic equity and capital markets exposure: Investment in Hangzhou Qunhe Information Technology Co., which has filed a listing application with the Hong Kong Stock Exchange, creates a potential catalyst for valuation uplift and access to capital.
• Robotics and medical tech play: Investment in the Fourier robotics project provides market entry into medical rehabilitation and academic research robotics solutions-adjacent, high-margin markets with long-term demand.
• Value-accretive M&A pipeline: Planned acquisition of Shenzhen Jianyuan, a polypeptide leader, is expected to strengthen product mix and enhance profitability via higher-margin biologics capabilities.
• Geographic expansion opportunity: 30% market share in southwestern China suggests significant room to increase penetration in other domestic regions and selectively abroad.
• Strong profitability improvement: Net profit grew from ¥0.85 billion in 2016 to ¥9.85 billion in 2023, signaling significant operating leverage and scalability of core businesses.

• Investor implications: R&D intensity and tech/biotech investments position the company for product premiumization and margin expansion; pending listings and M&A are potential near-to-medium-term catalysts.
• Execution risks to monitor: integration of Shenzhen Jianyuan, realization of synergies from robotics projects, and regional expansion execution beyond the southwest market.
• Potential upside drivers: successful HK listing of Hangzhou Qunhe, commercialization scale of Fourier robotics solutions in medical rehab, and cross-selling polypeptide products into existing distribution channels.